VIA
PCRX icon

Virtus Investment Advisers’s Pacira BioSciences PCRX Stock Holding History

Virtus Investment Advisers’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,500
Closed -$122K – 636
2024
Q4 		$122K Hold
6,500
– – 0.1% 241
2024
Q3 		$97.8K Buy
+6,500
New +$97.8K 0.08% 252